MethylGene Announces First Quarter 2005 Results

MethylGene a biopharmaceutical company, announced operational and financial results for the first quarter ended March 31, 2005. MethylGene also announced research results from its collaboration with EnVivo Pharmaceuticals and results from a collaboration with Johns Hopkins in the area of breast cancer research. "We continue to make progress advancing both of our clinical stage products and our multiple research programs, which will yield our next generation product candidate," said Mr. Donald F. Corcoran, president and CEO of MethylGene.

Yahoo News (http://biz.yahoo.com/bw/050428/285264.html?.v=1)